BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18668687)

  • 1. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.
    Frankenberg T; Miloh T; Chen FY; Ananthanarayanan M; Sun AQ; Balasubramaniyan N; Arias I; Setchell KD; Suchy FJ; Shneider BL
    Hepatology; 2008 Dec; 48(6):1896-905. PubMed ID: 18668687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.
    Chen F; Ghosh A; Shneider BL
    J Lipid Res; 2013 Feb; 54(2):379-85. PubMed ID: 23213138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATPase Class I Type 8B Member 1 and protein kinase C zeta induce the expression of the canalicular bile salt export pump in human hepatocytes.
    Chen F; Ellis E; Strom SC; Shneider BL
    Pediatr Res; 2010 Feb; 67(2):183-7. PubMed ID: 19809379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
    Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
    Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
    Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
    Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
    Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
    Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
    Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
    Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.
    Ananthanarayanan M; Li Y; Surapureddi S; Balasubramaniyan N; Ahn J; Goldstein JA; Suchy FJ
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G771-81. PubMed ID: 21330447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
    Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
    J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.
    Deng R; Yang D; Radke A; Yang J; Yan B
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.
    Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD
    J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.
    Ananthanarayanan M; Li S; Balasubramaniyan N; Suchy FJ; Walsh MJ
    J Biol Chem; 2004 Dec; 279(52):54348-57. PubMed ID: 15471871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
    Harris MJ; Kagawa T; Dawson PA; Arias IM
    J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump.
    Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M
    Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
    Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
    J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.